Innovating Works

Georg-Speyer-Haus

Desconocido
PLASTICAN: Cell Plasticity in Metastatic Colorectal Cancer CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG tramitó un H2020: ERC-2020-ADG Colorectal cancer (CRC) belongs to the most frequent tumor entities in both men and women. Although early detection and certain therapies ha...
2021-12-06 - 2026-12-31 | Financiado
INTERCEPT-MDS: Exploring cell to cell heterogeneity and exploiting epigenetic regulation for the interception of my... CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG participó en un H2020: H2020-MSCA-ITN-2020 Disease interception is a novel concept referring to treatment of a disease before the disease fully develops by removing altered cells. To...
2020-08-13 - 2024-12-31 | Financiado
EUbOPEN: EUbOPEN Enabling and Unlocking biology in the OPEN CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG participó en un H2020: H2020-JTI-IMI2-2019-17-two-stage The EUbOPEN partnership of excellence will aim to generate the largest freely available set of high-quality chemical inhibitors for human pr...
2020-05-11 - 2025-04-30 | Financiado
HemNichMDS: Functional and Molecular Analyses of the Interplay between Hematopoietic and Mesenchymal Niche Cells... CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG tramitó un H2020: ERC-2014-STG Myelodysplastic syndromes (MDS) are heterogeneous clonal hematopoietic stem cell diseases mainly affecting the elderly (45/100,000 in >70 ye...
2015-07-08 - 2022-01-31 | Financiado
ROSCAN: The role of ROS RNS during inflammation associated and sporadic carcinogenesis CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG tramitó un FP7: "A link between inflammation and cancer has been suspected over a long period of time and in recent years genetic evidence supporting such n...
Financiado
CELL-PID: Advanced Cell based Therapies for the treatment of Primary ImmunoDeficiency CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG participó en un FP7: Primary immune deficiencies (PID) are inherited disorders of the adaptive and innate immune system marked by severe infections, autoimmunity...
Financiado
PERSIST: Persisting Transgenesis CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG participó en un FP7: For many disabling or fatal diseases, there is pre-clinical or clinical evidence of the potential therapeutic efficacy of gene therapy and,...
Financiado
NET4CGD: Gene Therapy for X linked Chronic Granulomatous Disease CGD CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG participó en un FP7: This project is focused on the clinical development of a new orphan drug that can rapidly become a new treatment option for patients with th...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.